FXC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.849430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.689600E-01
Normal-vs-Stage2
1.790630E-01
Normal-vs-Stage3
6.858000E-02
Normal-vs-Stage4
7.241600E-01
Stage1-vs-Stage2
3.274000E-01
Stage1-vs-Stage3
5.581900E-02
Stage1-vs-Stage4
8.128400E-01
Stage2-vs-Stage3
1.408610E-01
Stage2-vs-Stage4
2.938800E-01
Stage3-vs-Stage4
1.088020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.987350E-01
Normal-vs-AfricanAmerican
5.303400E-01
Normal-vs-Asian
7.335700E-02
Caucasian-vs-AfricanAmerican
4.139600E-01
Caucasian-vs-Asian
4.927000E-01
AfricanAmerican-vs-Asian
2.071800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.771000E-01
Normal-vs-Female
9.857700E-02
Male-vs-Female
1.281820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.633580E-01
Normal-vs-Age(41-60Yrs)
2.337800E-01
Normal-vs-Age(61-80Yrs)
1.731380E-01
Normal-vs-Age(81-100Yrs)
2.351600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.351600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.669200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.040200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.033400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.271000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.383600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.313800E-01
Normal-vs-Daily Drinker
2.866400E-02
Normal-vs-Weekly Drinker
1.284820E-01
Normal-vs-Occasional Drinker
4.552200E-01
Normal-vs-Social Drinker
5.631400E-01
Non Drinker-vs-Daily Drinker
4.398000E-01
Non Drinker-vs-Weekly Drinker
8.769000E-01
Non Drinker-vs-Occasional Drinker
1.649050E-01
Non Drinker-vs-Social Drinker
1.601430E-01
Daily Drinker-vs-Weekly Drinker
6.145000E-01
Daily Drinker-vs-Occasional Drinker
3.658200E-02
Daily Drinker-vs-Social Drinker
4.302500E-02
Weekly Drinker-vs-Occasional Drinker
1.970640E-01
Weekly Drinker-vs-Social Drinker
2.017800E-01
Occasional Drinker-vs-Social Drinker
8.893000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.690500E-02
Normal-vs-Grade 2
2.236200E-02
Normal-vs-Grade 3
3.852200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.469000E-01
Grade 1-vs-Grade 3
9.982000E-01
Grade 1-vs-Grade 4
5.690500E-02
Grade 2-vs-Grade 3
4.767600E-01
Grade 2-vs-Grade 4
2.236200E-02
Grade 3-vs-Grade 4
3.852200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.719550E-01
Normal-vs-NonDiabetic
1.543640E-01
Diabetic-vs-NonDiabetic
7.505800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.276000E-01
Normal-vs-NoPancreatitis
1.508210E-01
Pancreatitis-vs-NoPancreatitis
1.118580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.172200E-01
Normal-vs-N1
1.612580E-01
N0-vs-N1
1.072770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.642400E-01
Normal-vs-TP53-NonMutant
5.632600E-01
TP53-Mutant-vs-TP53-NonMutant
5.994200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
